BT-CAP: a subcomponent-aware and anatomically constrained data augmentation framework for multi-modal brain tumor MRI
Amin Tavallaii1,2,3, Shamim Shah Ghasi3
1Computational Neurosurgery Lab, Department of Neurosurgery, Macquarie University, Sydney, NSW, Australia.
Frontiers in Radiology
|May 28, 2026
Summary
Brain Tumor Compositional Augmentation Pipeline (BT-CAP) enhances medical image analysis by creating realistic, subcomponent-aware MRI data. This method improves brain tumor segmentation accuracy without needing generative models, addressing data scarcity challenges.
Area of Science:
- Medical Image Analysis
- Artificial Intelligence in Medicine
- Radiology
Background:
- Data scarcity and class imbalance hinder medical image analysis, especially for brain tumor MRI segmentation.
- Existing augmentation methods lack subcomponent control or require extensive generative model training.
- Underrepresentation of brain tumor subcomponents (enhancing tumor, non-enhancing tumor, cystic component, peritumoral edema) poses a significant challenge.
Purpose of the Study:
- To introduce the Brain Tumor Compositional Augmentation Pipeline (BT-CAP) for subcomponent-aware, anatomically constrained augmentation of multi-modal MRI.
- To address limitations of existing augmentation strategies in low-data settings for brain tumor segmentation.
Main Methods:
- BT-CAP decomposes and recomposes tumor subcomponents using targeted operations like scaling, B-spline deformation, and inpainting.
- The pipeline ensures consistent application across MRI modalities and segmentation masks, generating label-ready volumes.
- Augmentation diversity and anatomical plausibility were evaluated on 50 BraTS-PEDs 2025 cases, producing 250 augmented volumes.
Main Results:
- BT-CAP achieved high structural diversity (mean SSIM 0.956 ± 0.014) with realistic intensity variations.
- Augmented data maintained anatomical integrity, with masks confined within brain boundaries and no edema-tumor core overlap.
- Segmentation performance improved by 6%-7% for tumor subcomponents and 2%-3% for overall tumor segmentation.
Conclusions:
- BT-CAP offers a novel class of compositional augmentation for anatomically structured, label-ready data generation without generative models.
- The framework is scalable and applicable to multi-class segmentation tasks facing data scarcity and requiring structural fidelity.
- The BT-CAP framework is publicly available for research use.
